Cognition Therapeutics Inc financial data

Symbol
CGTX on Nasdaq
Location
2403 Sidney Street, Suite 261, Pittsburgh, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 208 % -42.9%
Debt-to-equity 92.1 % +132%
Return On Equity -251 % -113%
Return On Assets -131 % -54.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73.5M shares +83.1%
Common Stock, Shares, Outstanding 65M shares +62%
Entity Public Float 56.3M USD +30.6%
Common Stock, Value, Issued 65K USD +62.5%
Weighted Average Number of Shares Outstanding, Basic 63.7M shares +59%
Weighted Average Number of Shares Outstanding, Diluted 63.7M shares +59%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 41.8M USD -7.9%
General and Administrative Expense 11.1M USD -16.4%
Operating Income (Loss) -52.9M USD +9.84%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.73M USD +19.6%
Net Income (Loss) Attributable to Parent -33M USD -6.15%
Earnings Per Share, Basic 0 USD/shares +29.8%
Earnings Per Share, Diluted 0 USD/shares +29.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.7M USD -62.3%
Assets, Current 19M USD -43.2%
Property, Plant and Equipment, Net 174K USD -25.6%
Operating Lease, Right-of-Use Asset 399K USD -31.8%
Assets 19.6M USD -42.9%
Accounts Payable, Current 771K USD -74.6%
Employee-related Liabilities, Current 1.09M USD -0.64%
Accrued Liabilities, Current 9.37M USD +54.6%
Liabilities, Current 12.4M USD +13.2%
Deferred Income Tax Liabilities, Net 110K USD -25.2%
Operating Lease, Liability, Noncurrent 229K USD -48%
Other Liabilities, Noncurrent 0 USD
Liabilities 12.6M USD +10.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -195K USD +2.01%
Retained Earnings (Accumulated Deficit) -190M USD -21%
Stockholders' Equity Attributable to Parent 7.03M USD -69.5%
Liabilities and Equity 19.6M USD -42.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.88M USD -36.3%
Net Cash Provided by (Used in) Financing Activities 1.3M USD -89.2%
Net Cash Provided by (Used in) Investing Activities -41K USD +69.4%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 65M shares +62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.58M USD -281%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.6M USD -59.5%
Deferred Tax Assets, Valuation Allowance 29.4M USD +32.4%
Deferred Tax Assets, Gross 29.5M USD +32%
Operating Lease, Liability 427K USD -31.6%
Payments to Acquire Property, Plant, and Equipment 41K USD -69.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -33M USD -6.82%
Lessee, Operating Lease, Liability, to be Paid 479K USD -33.3%
Property, Plant and Equipment, Gross 1.34M USD +0.3%
Operating Lease, Liability, Current 198K USD +7.61%
Lessee, Operating Lease, Liability, to be Paid, Year Two 87K USD -44.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 155K USD -31.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 52K USD -44.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 88K USD -3.3%
Deferred Tax Assets, Operating Loss Carryforwards 8.49M USD +24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 38K USD -58.7%
Operating Lease, Payments 56K USD 0%
Additional Paid in Capital 197M USD +9.42%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 27K USD +28.6%
Deferred Tax Assets, Net of Valuation Allowance 110K USD -25.2%
Share-based Payment Arrangement, Expense 2.64M USD -40.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%